Sorry, you need to enable JavaScript to visit this website.

MYLOTARG™ (gemtuzumab ozogamicin) Indications and Usage

1 INDICATIONS AND USAGE

1.1 Newly-Diagnosed CD33-positive Acute Myeloid Leukemia (AML)

MYLOTARG is indicated for the treatment of newly-diagnosed CD33-positive acute myeloid leukemia in adults and pediatric patients 1 month and older.

1.2 Relapsed or Refractory CD33-positive AML

MYLOTARG is indicated for the treatment of relapsed or refractory CD33-positive acute myeloid leukemia in adults and pediatric patients 2 years and older.

What's New

No Current Announcements.

Search

Please enter your search term(s) for MYLOTARG™